Minnesota SF3294 modifies prescription drug transparency provisions.

Minnesota SF3294 amends existing laws to enhance prescription drug transparency. Manufacturers, pharmacies, pharmacy benefit managers, and wholesale drug distributors must report detailed information about prescription drugs to the commissioner of health. This includes drug descriptions, acquisition costs, sales revenue, and rebate amounts. The commissioner must publicly post this information and notify reporting entities of their obligations. The bill also establishes fines for non-compliance and allows for exemptions in certain cases.

Minnesota SF3294 modifies prescription drug transparency provisions.

Minnesota SF3294 amends existing laws to enhance prescription drug transparency. Manufacturers, pharmacies, pharmacy benefit managers, and wholesale drug distributors must report detailed information about prescription drugs to the commissioner of health. This includes drug descriptions, acquisition costs, sales revenue, and rebate amounts. The commissioner must publicly post this information and notify reporting entities of their obligations. The bill also establishes fines for non-compliance and allows for exemptions in certain cases.